Christine Hilcenko

Christine Hilcenko

Auto-generated profile, based on publicly available information

Christine Hilcenko

MRC Laboratory of Molecular Biology, Cambridge, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Genes & Development
Verified
Journal Article
Open access
PDF file
AFAndrew J. Finch
Andrew J. Finch
CHChristine Hilcenko
Christine Hilcenko
NBNicolas Basse
Nicolas Basse
LDLesley F. Drynan
Lesley F. Drynan
BGBeatriz Goyenechea
Beatriz Goyenechea
AWAlan J. Warren
Alan J. Warren
Removal of the assembly factor eukaryotic initiation factor 6 (eIF6) is critical for late cytoplasmic maturation of 60S ribosomal subunits. In mammalian cells, the current model posits that eIF6 release is triggered following phosphorylation of Ser 235 by activated protein kinase C. In contrast, genetic studies in yeast indicate a requirement for the ortholog of theSBDS(Shwachman-Bodian-Diamond syndrome) gene that is mutated in the inherited leukemia predisposition disorder Shwachman-Diamond syndrome (SDS). Here, by isolating late cytoplasmic 60S ribosomal subunits fromSbds-deleted mice, we show that SBDS and the GTPase elongation factor-like 1 (EFL1) directly catalyze eIF6 removal in mammalian cells by a mechanism that requires GTP binding and hydrolysis by EFL1 but not phosphorylation of eIF6 Ser 235. Functional analysis of disease-associated missense variants reveals that the essential role of SBDS is to tightly couple GTP hydrolysis by EFL1 on the ribosome to eIF6 release. Furthermore, complementary NMR spectroscopic studies suggest unanticipated mechanistic parallels between this late step in 60S maturation and aspects of bacterial ribosome disassembly. Our findings establish a direct role for SBDS and EFL1 in catalyzing the translational activation of ribosomes in all eukaryotes, and define SDS as a ribosomopathy caused by uncoupling GTP hydrolysis from eIF6 release.

19 October 2015 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
FWFelix Weis
Felix Weis
EGEmmanuel Giudice
Emmanuel Giudice
MCMark Churcher
Mark Churcher
LJLi Jin
Li Jin
CHChristine Hilcenko
Christine Hilcenko
AWAlan Warren
Alan Warren

21 September 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MAMark D Allen
Mark D Allen
CGCharles G Grummitt
Charles G Grummitt
CHChristine Hilcenko
Christine Hilcenko
SMSandra Young Min
Sandra Young Min
LTLouise M Tonkin
Louise M Tonkin
AWAlan J Warren
Alan J Warren
Methylation of CpG dinucleotides is the major epigenetic modification of mammalian genomes, critical for regulating chromatin structure and gene activity. The mixed‐lineage leukaemia (MLL) CXXC domain selectively binds nonmethyl‐CpG DNA, and is required for transformation by MLL fusion proteins that commonly arise from recurrent chromosomal translocations in infant and secondary treatment‐related acute leukaemias. To elucidate the molecular basis of nonmethyl‐CpG DNA recognition, we determined the structure of the human MLL CXXC domain by multidimensional NMR spectroscopy. The CXXC domain has a novel fold in which two zinc ions are each coordinated tetrahedrally by four conserved cysteine ligands provided by two CGXCXXC motifs and two distal cysteine residues. We have identified the CXXC domain DNA binding interface by means of chemical shift perturbation analysis, cross‐saturation transfer and site‐directed mutagenesis. In particular, we have shown that residues in an extended surface loop are in close contact with the DNA. These data provide a template for the design of specifically targeted therapeutics for poor prognosis MLL‐associated leukaemias.

1 May 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CSCamille Shammas
Camille Shammas
TMTobias F. Menne
Tobias F. Menne
CHChristine Hilcenko
Christine Hilcenko
SMStephen R. Michell
Stephen R. Michell
BGBeatriz Goyenechea
Beatriz Goyenechea
AWAlan J. Warren
Alan J. Warren
Shwachman-Diamond Syndrome (SDS) is an autosomal recessive disorder characterized by bone marrow failure with significant predisposition to the development of poor prognosis myelodysplasia and leukemia, exocrine pancreatic failure and metaphyseal chondrodysplasia. Although the SBDS gene mutated in this disorder is highly conserved in Archaea and all eukaryotes, the function is unknown. To interpret the molecular consequences of SDS-associated mutations, we have solved the crystal structure of the Archaeoglobus fulgidus SBDS protein orthologue at a resolution of 1.9 angstroms, revealing a three domain architecture. The N-terminal (FYSH) domain is the most frequent target for disease mutations and contains a novel mixed alpha/beta-fold identical to the single domain yeast protein Yhr087wp that is implicated in RNA metabolism. The central domain consists of a three-helical bundle, whereas the C-terminal domain has a ferredoxin-like fold. By genetic complementation analysis of the essential Saccharomyces cerevisiae SBDS orthologue YLR022C, we demonstrate an essential role in vivo for the FYSH domain and the central three-helical bundle. We further show that the common SDS-related K62X truncation is non-functional. Most SDS-related missense mutations that alter surface epitopes do not impair YLR022C function, but mutations affecting residues buried in the hydrophobic core of the FYSH domain severely impair or abrogate complementation. These data are consistent with absence of homozygosity for the common K62X truncation mutation in individuals with SDS, indicating that the SDS disease phenotype is a consequence of expression of hypomorphic SBDS alleles and that complete loss of SBDS function is likely to be lethal.

7 February 2013 in Blood
Verified
Journal Article
Open access
PDF file
CHChristine Hilcenko
Christine Hilcenko
PSPaul J. Simpson
Paul J. Simpson
AFAndrew J. Finch
Andrew J. Finch
FBFrank R. Bowler
Frank R. Bowler
MCMark J. Churcher
Mark J. Churcher
AWAlan J. Warren
Alan J. Warren
The recessive disorder poikiloderma with neutropenia (PN) is caused by mutations in the C16orf57 gene that encodes the highly conserved USB1 protein. Here, we present the 1.1 Å resolution crystal structure of human USB1, defining it as a member of the LigT-like superfamily of 2H phosphoesterases. We show that human USB1 is a distributive 3′-5′ exoribonuclease that posttranscriptionally removes uridine and adenosine nucleosides from the 3′ end of spliceosomal U6 small nuclear RNA (snRNA), directly catalyzing terminal 2′, 3′ cyclic phosphate formation. USB1 measures the appropriate length of the U6 oligo(U) tail by reading the position of a key adenine nucleotide (A102) and pausing 5 uridine residues downstream. We show that the 3′ ends of U6 snRNA in PN patient lymphoblasts are elongated and unexpectedly carry nontemplated 3′ oligo(A) tails that are characteristic of nuclear RNA surveillancetargets. Thus, our study reveals a novel quality control pathway in which posttranscriptional 3′-end processing by USB1 protects U6 snRNA from targeting and destruction by the nuclear exosome. Our data implicate aberrant oligoadenylation of U6 snRNA in the pathogenesis of the leukemia predisposition disorder PN. Key Points Crystal structure of human USB1 identifies it as a member of the LigT-like superfamily of 2H phosphoesterases. USB1 protects spliceosomal U6 small nuclear RNA from aberrant 3′ oligoadenylation.

22 May 2019 in eLife
Verified
Journal Article
Open access
VKVasileios Kargas
Vasileios Kargas
PCPablo Castro-Hartmann
Pablo Castro-Hartmann
NENorberto Escudero-Urquijo
Norberto Escudero-Urquijo
KDKyle Dent
Kyle Dent
CHChristine Hilcenko
Christine Hilcenko
AWAlan Warren
Alan Warren
During their final maturation in the cytoplasm, pre-60S ribosomal particles are converted to translation-competent large ribosomal subunits. Here, we present the mechanism of peptidyltransferase centre (PTC) completion that explains how integration of the last ribosomal proteins is coupled to release of the nuclear export adaptor Nmd3. Single-particle cryo-EM reveals that eL40 recruitment stabilises helix 89 to form the uL16 binding site. The loading of uL16 unhooks helix 38 from Nmd3 to adopt its mature conformation. In turn, partial retraction of the L1 stalk is coupled to a conformational switch in Nmd3 that allows the uL16 P-site loop to fully accommodate into the PTC where it competes with Nmd3 for an overlapping binding site (base A2971). Our data reveal how the central functional site of the ribosome is sculpted and suggest how the formation of translation-competent 60S subunits is disrupted in leukaemia-associated ribosomopathies.